Skip to main content
Top
Published in: Indian Journal of Hematology and Blood Transfusion 4/2020

01-10-2020 | Hemophilia | Short Communication

Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre

Authors: Swati Patel, V. P. Krishnan, Purva Kanvinde, Sangeeta Mudaliar, Nitin Shah, Archana Swami, Mukesh Desai, Bharat Agarwal

Published in: Indian Journal of Hematology and Blood Transfusion | Issue 4/2020

Login to get access

Abstract

To study the clinical course of patients with sickle cell anemia and coinherited hematological disorders. Retrospective analysis of clinical data of patients enrolled at our hospital over last 7 years was performed. Eighty four patients of symptomatic sickling disorders were registered during this period, comprising of HbSS (n = 49), HbS-β thalassemia (n = 28), HbS-HbD disease (n = 5), HbS-β thalassemia with G6PD deficiency (n = 1) and HbS-hemophilia A (n = 1). Among HbS-β thalassemia, 18% suffered from occasional pain crises and 27% required occasional blood transfusion. 40% patients with HbS-HbD disease required occasional blood transfusions, one patient was transfusion dependent, while none suffered from crisis episodes. Patient with HbS-β thalassemia with G6PD deficiency had increased transfusion requirement during first 3 years of life, which decreased after that. Patient with HbS and severe hemophilia A had only one episode of severe bleeding, suffered from 1 crisis episode. In conclusion, HbA reduces severity of HbS in HbS-β + thalassemia. HbS-HbD disease can manifest as a transfusion dependent illness. HbSS reduces severity of G6PD deficiency after first few years of life. HbSS and hemophilia coinheritance ameliorates symptoms of hemophilia.
Literature
1.
go back to reference Serjeant GR, Serjeant BE (2001) Sickle cell disease. Oxford University Press, Oxford Serjeant GR, Serjeant BE (2001) Sickle cell disease. Oxford University Press, Oxford
2.
go back to reference Nathan and Oski’s Hematology and oncology of infancy and childhood, 8th edition, Chapter 20, pp 675–714 Nathan and Oski’s Hematology and oncology of infancy and childhood, 8th edition, Chapter 20, pp 675–714
3.
go back to reference Platt OS, Brambilla DJ, Rosse WF et al (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644CrossRef Platt OS, Brambilla DJ, Rosse WF et al (1994) Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 330:1639–1644CrossRef
4.
go back to reference Agrawal RK, Patel RK, Shah V, Nainiwal L, Trivedi B (2014) Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus 30(2):91–96CrossRef Agrawal RK, Patel RK, Shah V, Nainiwal L, Trivedi B (2014) Hydroxyurea in sickle cell disease: drug review. Indian J Hematol Blood Transfus 30(2):91–96CrossRef
6.
go back to reference Patel S, Purohit P, Ranjeet SM, Dehury S, Meher S, Sahoo S et al (2014) The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab—a single centre experience in eastern India. Pediatr Blood Cancer 61(8):1341–1346 Patel S, Purohit P, Ranjeet SM, Dehury S, Meher S, Sahoo S et al (2014) The effect of hydroxyurea on compound heterozygotes for sickle cell-hemoglobin D-Punjab—a single centre experience in eastern India. Pediatr Blood Cancer 61(8):1341–1346
7.
go back to reference Adachi K, Kim J, Ballas S, Surrey S, Asakura T (1988) Facilitation of Hb S polymerization by the substitution of Glu for Gln at 121. J Biol Chem 263(12):5607–5610 Adachi K, Kim J, Ballas S, Surrey S, Asakura T (1988) Facilitation of Hb S polymerization by the substitution of Glu for Gln at 121. J Biol Chem 263(12):5607–5610
8.
go back to reference Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42:267–278 Nkhoma ET, Poole C, Vannappagari V, Hall SA, Beutler E (2009) The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis. Blood Cells Mol Dis 42:267–278
10.
go back to reference Benkerrou M, Alberti C, Couque N, Haouari Z, Ba A, Missud F et al (2013) Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol 163:646–654 Benkerrou M, Alberti C, Couque N, Haouari Z, Ba A, Missud F et al (2013) Impact of glucose-6-phosphate dehydrogenase deficiency on sickle cell anaemia expression in infancy and early childhood: a prospective study. Br J Haematol 163:646–654
11.
go back to reference Antwi-Baffour S, Kofi Adjei J, Owadee Forson P, Akakpo S, Kyeremeh R, Abdulai Seidu M (2019) Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia 2019:Article ID 3179173, 9 pages Antwi-Baffour S, Kofi Adjei J, Owadee Forson P, Akakpo S, Kyeremeh R, Abdulai Seidu M (2019) Comorbidity of glucose-6-phosphate dehydrogenase deficiency and sickle cell disease exert significant effect on RBC indices. Anemia 2019:Article ID 3179173, 9 pages
12.
go back to reference Simpore J, Ilboudo D, Damintoti K, Sawadogo L, Maria E, Binet S et al (2007) Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso. Pak J Biol Sci 10(3):409–414 Simpore J, Ilboudo D, Damintoti K, Sawadogo L, Maria E, Binet S et al (2007) Glucose-6-phosphate dehydrogenase deficiency and sickle cell disease in Burkina Faso. Pak J Biol Sci 10(3):409–414
13.
go back to reference Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH (2011) Fetal hemoglobin in sickle cell anemia. Blood 118:19–27 Akinsheye I, Alsultan A, Solovieff N, Ngo D, Baldwin CT, Sebastiani P, Chui DH, Steinberg MH (2011) Fetal hemoglobin in sickle cell anemia. Blood 118:19–27
14.
go back to reference Maier-Redelsperger, Noguchi M, de Montalembert CT, Rodgers M, Schechter GP, Gourbil AN et al (1994) Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: parisian prospective study on sickle cell disease. Blood 84:3182–3188 Maier-Redelsperger, Noguchi M, de Montalembert CT, Rodgers M, Schechter GP, Gourbil AN et al (1994) Variation in fetal hemoglobin parameters and predicted hemoglobin S polymerization in sickle cell children in the first two years of life: parisian prospective study on sickle cell disease. Blood 84:3182–3188
15.
go back to reference Glenn LD, Lovely RM, Goldsmith JC (1991) Combined sickle cell anemia and mild hemophilia a: successful treatment of hemorrhage with DDAVP. Am J Hematol 37(1):64 Glenn LD, Lovely RM, Goldsmith JC (1991) Combined sickle cell anemia and mild hemophilia a: successful treatment of hemorrhage with DDAVP. Am J Hematol 37(1):64
16.
go back to reference Kumar M (1997) Rare combination of homozygous sickle cell disease (Hb SS) and haemophilia B in a paediatric patient. Herring RA Br J Haematol 98(3):780–781 Kumar M (1997) Rare combination of homozygous sickle cell disease (Hb SS) and haemophilia B in a paediatric patient. Herring RA Br J Haematol 98(3):780–781
19.
go back to reference Ataga KI (2009) Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 94:1481–1484 Ataga KI (2009) Hypercoagulability and thrombotic complications in hemolytic anemias. Haematologica 94:1481–1484
Metadata
Title
Clinical Course of Patients With Sickle Cell Anemia and Co-inherited Hematological Disorders: Experience at a Tertiary Hematological Centre
Authors
Swati Patel
V. P. Krishnan
Purva Kanvinde
Sangeeta Mudaliar
Nitin Shah
Archana Swami
Mukesh Desai
Bharat Agarwal
Publication date
01-10-2020
Publisher
Springer India
Published in
Indian Journal of Hematology and Blood Transfusion / Issue 4/2020
Print ISSN: 0971-4502
Electronic ISSN: 0974-0449
DOI
https://doi.org/10.1007/s12288-020-01303-x

Other articles of this Issue 4/2020

Indian Journal of Hematology and Blood Transfusion 4/2020 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine